Medical Science Liaison
Pubblicato il 15-10-2026 - Quetzaltx in Verona
Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is also developing a pre-clinical asset QTX-2102, an advanced, next-generation antifungal and antiparasitic therapy designed to enhance efficacy while minimizing toxicity. Our mission is to push the boundaries of treatment possibilities, delivering hope and life-changing solutions to those who need them most. Contractor Medical Science Liaison (MSL) – Italy/Germany Territory Haematology / Oncology – Phase 3 Clinical Trial Support Role Overview We are seeking an experienced contractor Medical Science Liaison (MSL) to support a multinational Phase 3 haematology/oncology clinical trial across Italy and Germany. This field-based role will focus on scientific engagement with investigators and treatment centres, supporting trial awareness,
operational engagement, and high-quality scientific exchange within a compliant framework. The successful candidate will work independently across a geographically distributed territory and act as a key scientific interface between the company and external stakeholders. Territory Coverage Primary territories: * Italy * Germany Travel within the assigned territory and attendance at relevant scientific meetings/congresses will be required. Time in Field Approximately 70–80% field-focused activity expected. Key Responsibilities * Develop and maintain scientific relationships with investigators, referral centres, and relevant healthcare professionals * Support scientific engagement around an ongoing Phase 3 haematology clinical trial * Deliver high-quality, non-promotional scientific exchange in compliance with applicable regulations and company SOPs * Support trial awareness and operational engag